Christine Ryan

Christine Ryan is an Instructor in Medicine at Harvard Medical School and an attending physician in the Lymphoma Division at Dana-Farber Cancer Institute (DFCI). Her academic and clinical work focuses on B-cell lymphomas, particularly leveraging BH3 profiling in clinical trials to identify therapeutic vulnerabilities and predict treatment responses in chronic lymphocytic leukemia (CLL) and Richter’s Syndrome.

Education:

• Bachelor's degree from University of California, Los Angeles (UCLA)
• M.D. from Stanford University School of Medicine (2017)
• Residency in Internal Medicine at Brigham and Women's Hospital
• Fellowship in Hematology/Oncology at Dana-Farber Cancer Institute/Mass General Brigham

Research Interests: Christine’s work integrates clinical trials with translational research, emphasizing novel therapeutics in hematologic malignancies. She employs BH3 profiling to explore therapeutic targets in CLL and Richter’s Syndrome, addressing critical unmet clinical needs. Her research bridges laboratory findings with patient care, aiming to improve outcomes through precision medicine approaches.

Awards: No specific awards listed in the provided text.

Advising & Grants: While her role involves clinical and translational research, specific grant details or trainee advising programs are not detailed here. She contributes to the Davids Lab’s postdoctoral research and collaborates with colleagues across DFCI and Harvard Medical School.

Labs & Teams: Christine is part of the Davids Lab and collaborates with current lab members including Anna Chung, Fen Zhu, and Nathalie Javidi-Sharifi, among others. Alumni of the lab include Xiao Lv, Charles Herbaux, and others listed under team members.